B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis

Overview of attention for article published in Journal of Clinical Immunology, September 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

patent: 4 patents

Citations

dimensions_citation: 201 Dimensions

Readers on

mendeley: 136 Mendeley

Summary News Blogs Patents Dimensions citations

So far, Altmetric has seen 1 blog post.

How does CD20 depletion work in progressive MS?….Is it all in the growth factors?

Multiple Sclerosis Research, 25 Mar 2024

How do you explain the benefit of ocrelizumab in progressive MS….is it because it blocks active lesion formation to prevent B…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.